Fresenius SE & Co. KGaA
Price data unavailable
Track FSNUY in your trading journalAbout Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA (FSNUY) is a US-listed equity tracked across major market indices. FRESENIUS SE S/ADR
FINOTAUR provides free research summaries, news aggregation, and fundamentals for FSNUY to support both active traders and long-term investors.
Fundamentals
| Revenue (TTM) | — |
| Net Income (TTM) | — |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | — |
| Debt-to-Equity | — |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·May 13
Saudi Arabia Pharmaceutical CDMO Market Research Report 2025 Featuring Tabuk Manufacturing, Lifera, Saudi Bio, Fresenius Kabi, Hikma Pharma, Pfizer, Novartis
- GlobeNewswire Inc.·May 9
$9.48 Bn Medical Foods for Inborn Errors of Metabolism Market Opportunities and Strategies to 2034
- GlobeNewswire Inc.·Apr 17
Infusion Pumps Market to Soar at a CAGR of ~10% by 2032, Owing to the Advancements in Technology and Increased Demand in Healthcare | DelveInsight
Want real-time analysis on FSNUY?
Track it free in your trading journal. Log trades, tag setups, and review your edge.